Newsroom

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

The molecule restores the activity of neurons and neural circuits in a model of the disease.

Novartis works tirelessly with third-party organizations to improve access to cancer care.

Suzan Akello describes what life has been like since her cancer diagnosis.

Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.

New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.

Healthy Family program combines health education with improved access to doctors and medicines.

After a diagnosis of childhood cancer, Ryan faced the diagnosis and treatment of leukemia head- on with the support of his family and community.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Ron Hollander, president of the International Neuroendocrine Cancer Alliance, talks to us about patient advocacy.